Enviar artigo por via de e-mail Internalization of Vectorized Liposomes Loaded with Plasmid DNA in C6 Glioma Cells
- Autores: Mel’nikov P.1,2, Baklaushev V.2, Gabashvili A.1, Nukolova N.1,3, Kuznetsov I.4, Cherepanov S.1, Koshkin F.1, Leopol’d A.1, Chekhonin V.1,3
-
Afiliações:
- Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
- Federal Clinical Research Centre, Federal Medical-Biological Agency
- Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University
- Department of Chemical Enzymology, Faculty of Biology, M. V. Lomonosov Moscow State University
- Edição: Volume 163, Nº 1 (2017)
- Páginas: 114-122
- Seção: Cell Technologies in Biology and Medicine
- URL: https://journals.rcsi.science/0007-4888/article/view/238700
- DOI: https://doi.org/10.1007/s10517-017-3750-x
- ID: 238700
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
We studied internalization of vector nanocarriers loaded with plasmid DNA into C6 glioma cells. For improving selectivity of plasmid delivery, the liposomes were conjugated with monoclonal antibodies to VEGF and its receptor VEGFR2. Flow cytofluorometry and laser scanning confocal microscopy showed more intensive (more than 2-fold) internalization and accumulation of antibody-vectorized liposomes in C6 glioma cells in comparison with the control (liposomes conjugated with non-specific antibodies and non-vectorized liposomes). Using quantitative analysis of fluorescent signal, we showed that cationic immunoliposomes significantly more effective delivered pCop-Green-N plasmid DNA and ensured effective transfection of C6 glioma cells.
Sobre autores
P. Mel’nikov
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; Federal Clinical Research Centre, Federal Medical-Biological Agency
Autor responsável pela correspondência
Email: proximopm@gmail.com
Rússia, Moscow; Moscow
V. Baklaushev
Federal Clinical Research Centre, Federal Medical-Biological Agency
Email: proximopm@gmail.com
Rússia, Moscow
A. Gabashvili
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: proximopm@gmail.com
Rússia, Moscow
N. Nukolova
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University
Email: proximopm@gmail.com
Rússia, Moscow; Moscow
I. Kuznetsov
Department of Chemical Enzymology, Faculty of Biology, M. V. Lomonosov Moscow State University
Email: proximopm@gmail.com
Rússia, Moscow
S. Cherepanov
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: proximopm@gmail.com
Rússia, Moscow
F. Koshkin
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: proximopm@gmail.com
Rússia, Moscow
A. Leopol’d
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation
Email: proximopm@gmail.com
Rússia, Moscow
V. Chekhonin
Department of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of the Russian Federation; Department of Medical Nanobiotechnologies, Medico-Biological Faculty, N. I. Pirogov National Research Medical University
Email: proximopm@gmail.com
Rússia, Moscow; Moscow
